BioSpace News Archive

PolyPid Announces Closing of Underwritten Public Offering, Including Full Exercise of Overallotment Option, and Concurrent Private Placement with $11.4 Million in Aggregate Gross Proceeds

PolyPid Ltd. announced the closing of an underwritten public offering of ordinary shares, no par value, with gross proceeds of approximately $7.1 million, which includes the full exercise of the underwriter’s option to purchase additional Ordinary Shares.

March 31, 2023
·
5 min read
BioMidwest

RAYUS Radiology Adds New Wide-Bore 3T MRI Scanner to Its Fleet of Industry-Leading Imaging Solutions

RAYUS Radiology announces the latest addition to its line of cutting-edge imaging solutions serving the state of Utah with the installation of a new MAGNETOM Lumina MRI scanner from Siemens Healthineers at its Redwood location in Taylorsville, Utah.

March 31, 2023
·
2 min read
Business

Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Motus GI Holdings, Inc. reported its financial results for the fourth quarter and year ended December 31, 2022, and provided a corporate update.

March 31, 2023
·
10 min read
Lone Star Bio

Savara Announces New Employment Inducement Grant - March 31, 2023

Savara Inc., a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the grant of inducement awards to two new employees.

March 31, 2023
·
1 min read
Policy

FDA Roundup: March 31, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

March 31, 2023
·
8 min read
Business

Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

Athersys, Inc. announced financial results for the three and 12 months ended December 31, 2022, and provided a business update.

March 31, 2023
·
14 min read
Pharm Country

AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering

AnPac Bio-Medical Science Co., Ltd. announced that it has entered into a securities purchase agreement with certain institutional investors to purchase $3.0 million of its American Depositary Shares, pre-funded warrants to purchase ADSs and warrants to purchase ADSs in a registered direct offering.

March 31, 2023
·
8 min read
Biotech Bay

Aridis Provides Corporate Update

Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.

March 31, 2023
·
7 min read